李双弟 主任医师，讲师
硕士招生类型：专业型
硕士招生专业：妇产科学
博士招生类型：无
博士招生专业：无
所在院系：附属第一妇婴保健院
联系方式：lishuangdi21@126.com
课题组链接：
研究方向
主要任职
科研业绩

异位妊娠临床与基础研究
上海市医学会内膜异位症学组委员；上海市医学会计划生育学组委员
李双弟，妇产科博士，主任医师。上海市医学会子宫内膜异位症学组委员，上海市医学会计划生育学组委员。上海市第一妇婴保健院急诊妇科主任。擅长于异位妊娠、切口妊娠的手术、药物和介入治疗，子宫内膜异位症或子宫肌瘤、子宫肌腺症的腹腔镜手术和药物综合治疗，输卵管阻塞的宫腹腔镜联合治疗。承担上海市卫健委，浦东新区等多项课题，发表科研论文20余篇。
已发表的主要SCI收录论文：
1.Li L, Yu P, Zhang P, Wu H, Chen Q, Li S#, Wang Y#. Upregulation of hsa_circ_** suppresses the progression of ovarian cancer by regulating the miR-760/SOCS3 pathway. Cancer Med. 2020 Feb 5.
2.Ye L*, Li S*, Lu W, He Q, Li Y, Li B, Wang X, Yan Q, Wan X. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes? Oncologist. 2019 Dec;24(12):e1381-e1387.
3.Li S, Ji X, Wang R, Miao Y. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells. Arch Gynecol Obstet. 2019 May;299(5):1443-1451.
4.Li S, Zhu Y, Zhang T, Hang Y, Chen Q, Jin Y. Cai's Neiyi Prescription promotes apoptosis and inhibits inflammation in endometrial stromal cells with endometriosis through inhibiting USP10. Biotechnol Appl Biochem. 2019 Mar;66(2):231-239
5.Bao W*, Zhang Y*, Li S*, Fan Q, Qiu M, Wang Y, Li Y, Ji X, Yang Y, Sang Z, Xu W, Yang Y, Wu S, Zhu Y. miR 107 5p promotes tumor proliferation and invasion by targeting estrogen receptor α in endometrial carcinoma. Oncol Rep. Oncol Rep. 2019 Mar;41(3):1575-1585. doi: 10.3892/or.2018.6936. Epub 2018 Dec 18.
6.Li S, Zhang J, Wan X. Role of miRNAs in endometrial cancer. Histol Histopathol. 2015 May;30(5):539-48.
7.Li S, Wang Y, Zhang J. L-selectin ligands expression in human fallopian tube epithelia of tubal pregnancies. Biol Reprod. 2014 Jun;90(6):133.
8.Zhang J, Li S*, Yan Q, Chen X, Yang Y, Liu X, Wan X*. Interferon-β induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells. PLoS One. 2013 Dec 16;8(12):e81366.
9.Li SD, Zhang JR, Wang YQ, Wan XP.The role of microRNAs in ovarian cancer initiation and progression.J Cell Mol Med. 2010 Sep;14(9):2240-9.